Alnylam to Pay Tekmira $65M as Part of Litigation Settlement

Nov. 13, 2012

By Doug Macron

Just days before they were scheduled to go to trial, Alnylam Pharmaceuticals and Tekmira Pharmaceuticals announced that they have hammered out a settlement to their protracted patent-infringement and technology-misappropriation lawsuits.

Read this complete story at Genomeweb.